Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
tumor suppression
Research
The immune connection between mutated genes and cancer
More than 100 mutated cancer-suppressor genes work by blocking the immune system from recognizing and destroying tumors, a new study reveals.
Arlene Weintraub
Sep 16, 2021 2:00pm
iTeos reels in $125M to shepherd I-O prospects through clinic
Apr 1, 2020 2:32pm
Celgene strikes Obsidian deal to boost CAR-T options
Jan 18, 2019 8:50am
AstraZeneca, Syndax ally to test PD-L1 drug and CSF1R inhibitor
Feb 1, 2018 9:16am
